Congenital adrenal hyperplasia: Phenotype and genotype

Journal of Pediatric Endocrinology and Metabolism

Volumn 15, Issue SUPPL. 5, 2002, Pages 1329-1340

  Hughes, Ieuan ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adrenal incidentaloma; Adrenalectomy; Congenital adrenal hyperplasia; CYP21; Cytochrome P450c21; Genotype; Prenatal treatment

Indexed keywords

ANDROGEN; CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; HLA A3 ANTIGEN; HYDROCORTISONE; HYDROXYPROGESTERONE; MESSENGER RNA; METADRENALIN; MINERALOCORTICOID; STEROID 21 MONOOXYGENASE; STEROID HORMONE;

ADRENAL TUMOR; ADRENALECTOMY; ALLELE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHROMOSOME 6P; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HYPERANDROGENISM; NEWBORN SCREENING; ONSET AGE; PATHOGENESIS; PHENOTYPE; PRENATAL SCREENING; SIDE EFFECT; STEROID THERAPY; STEROIDOGENESIS; SUBSTITUTION THERAPY; TREATMENT PLANNING;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL HYPERPLASIA, CONGENITAL; FEMALE; GENOTYPE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PHENOTYPE; PRENATAL DIAGNOSIS; STEROID 21-HYDROXYLASE;

EID: 0036918611     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hughes IA. Congenital adrenal hyperplasia-a continuum of disorders. Lancet 1998; 352: 752-754.
2. Ahmed SF, Hughes IA. The clinical assessment of intersex. Curr Paediatr 2000; 10: 269-274.
3. Prader A. Der Genitalbefund beim Pseudohermaphroditismus femininus des kongenitalen adrenogenitalen Syndromes: Morphologie, Haufigkeit, Entwicklung und Vererbung der verschiedenen Genitalformen. Helv Paediatr Acta 1954; 9: 231-248.
4. Pang S, Hotchkiss J, Drash AL, Levine LS, New MI. Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1977; 45: 1003-1008.
5. Honour JW, Brook CG. Clinical indications for the use of urinary steroid profiles in neonates and children. Ann Clin Biochem 1997; 34: 45-54.
6. Dupont B, Oberfield SE, Smithwick EM, Lee TD, Levine LS. Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet 1977; ii: 1309-1312.
7. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21: 245-291.
8. Acerini CL, Hughes IA. 21-Hydroxylase deficiency defects and their phenotype. In: Hughes IA, Clark AJL, eds. Adrenal Disease in Childhood: Clinical and Molecular Aspects. Basel: Karger, 2000; 93-111.
9. Wedell A, Thilen A, Ritzén EM, Stengler B, Luthman H. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 1994; 78: 1145-1152.
10. Jääskeläinen J, Levo A, Voutilainen R, Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab 1997; 82: 3293-3297.
11. Levo A, Partanen J. Novel mutations in the human CYP21 gene. Prenat Diagn 2001; 21: 885-889.
12. Dacou-Voutetakis C, Maniati-Christidi M, Dracopoulou-Vabouli M. Genetic aspects of congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 2001; 14 (Suppl 5): 1303-1308.
13. Baumgartner-Parzer SM, Schulze E, Waldhäusl W, Pauschenwein S, Rondot S, Nowotny P, Meyer K, Frisch H, Waldhauser F, Vierhapper H. Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation. J Clin Endocrinol Metab 2001; 86: 4771-4775.
14. Lee HH. CYP21 mutations and congenital adrenal hyperplasia. Clin Genet 2001; 59: 293-301.
15. Koyama S, Toyoura T, Saisho S, Shimozawa K, Yata J. Genetic analysis of Japanese patients with 21-hydroxylase deficiency: identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21. J Clin Endocrinol Metab 2002; 87: 2668-2673.
16. Dain LB, Buzzalino ND, Oneto A, Belli S, Stivel M, Pasqualini T, Minutolo C, Charreau EH, Alba LG. Classical and nonclassical 21-hydroxylase deficiency: a molecular study of Argentine patients. Clin Endocrinol (Oxf) 2002; 56: 239-245.
17. Higashi Y, Tanae A, Inoue H, Hiromasa T, Fujii-Kuriyama Y. Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. Proc Natl Acad Sci USA 1988; 85: 7486-7490.
18. Sherman SL, Aston CE, Morton NE, Speiser PW, New MI. A segregation and linkage study of classical and nonclassical 21-hydroxylase deficiency. Am J Hum Genet 1988; 42: 830-838.
19. Krone N, Braun A, Weinert S, Peter M, Roscher AA, Partsch CJ, Sippell WG. Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasia. Clin Chem 2002; 48: 818-825.
20. David M, Forest MG. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr 1984; 105: 799-803.
21. Jaffe RB, Mesiano S, Smith R, Coulter CL, Spencer SJ, Chakravorty A. The regulation and role of fetal adrenal development in human pregnancy. Endocr Res 1998; 24: 919-926.
22. Forest M. Prenatal diagnosis, treatment, and outcome in infants with congenital adrenal hyperplasia. Curr Opin Endocrinol Diabet 1998; 4: 209-217.
23. Lajic S, Wedell A, Bui TH, Ritzén EM, Holst M. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1998; 83: 3872-3880.
24. New MI, Carlson A, Obeid J, Marshall I, Cabrera MS, Goseco A, Lin-Su K, Putnam AS, Wei JQ, Wilson RC. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 2001; 86: 5651-5657.
25. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-67.
26. Honour JW, Torresani T. Evaluation of neonatal screening for congenital adrenal hyperplasia. Horm Res 2001; 55: 206-211.
27. Nordenström A, Wedell A, Hagenfeldt L, Marcus C, Larsson A. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics 2001; 108: e68.
28. Nordenström A, Thilen A, Hagenfeldt L, Larsson A, Wedell A. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84: 1505-1509.
29. Merke DP, Bornstein SR, Avila NA, Chrousos GP. NIH Conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Intern Med 2002; 136: 320-334.
30. Frisch H, Waldhauser F, Lebl J, Sólyom J, Hargitai G, Kovács J, Pribilincova. Z, Kržišnik C, Battelino T. Congenital adrenal hyperplasia: lessons from a multinational study. Horm Res 2002; 57 (Suppl 2): 95-101.
31. White PC, Speiser PW. Long-term consequences of childhood-onset congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 2002; 16: 273-288.
32. Hughes IA. Congenital adrenal hyperplasia: 21-hydroxylase deficiency in the newborn and during infancy. Semin Repro Med; in press.
33. Linder BL, Esteban NV, Yergey AL, Winterer JC, Loriaux DL, Cassorla F. Cortisol production rate in childhood and adolescence. J Pediatr 1990; 117: 892-896.
34. Charmandari E, Johnston A, Brook CG, Hindmarsh PC. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Endocrinol 2001; 169: 65-70.
35. Bobba A, Marra E, Lattanzio P, Iolascon A, Giannattasio S. Characterization of the CYP21 gene 5′ flanking region in patients affected by 21-OH deficiency. Hum Mutat 2000; 15: 481.
36. Mornet E, Gibrat JF. A 3D model of human P450c21: study of the putative effects of steroid 21-hydroxylase gene mutations. Hum Genet 2000; 106: 330-339.
37. Winkel CA, Casey ML, Worley RJ, Madden JD, MacDonald PC. Extraadrenal steroid 21-hydroxylase activity in a woman with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1983; 56: 104-107.
38. Bornstein SR, Tian H, Haidan A, Bottner A, Hiroi N, Eisenhofer G, McCann SM, Chrousos GP, Roffler-Tarlov S. Deletion of tyrosine hydroxylase gene reveals functional interdependence of adrenocortical and chromaffin cell system in vivo. Proc Natl Acad Sci USA 2000; 97: 14742-14747.
39. Bornstein SR, Tajima T, Eisenhofer G, Haidan A, Aguilera G. Adrenomedullary function is severely impaired in 21-hydroxylase-deficient mice. FASEB J 1999; 13: 1185-1194.
40. Charmandari E, Eisenhofer G, Mehlinger SL, Carlson A, Wesley R, Keil MF, Chrousos GP, New MI, Merke DP. Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. J Clin Endocrinol Metab 2002; 87: 3031-3037.
41. Van Wyk JJ, Gunther DF, Ritzén EM, Wedell A, Cutler GB Jr, Migeon CJ, New MI. The use of adrenalectomy as a treatment for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1996; 81: 3180-3190.
42. Bruining H, Bootsma AH, Koper JW, Bonjer J, de Jong FF, Lamberts SW. Fertility and body composition after laparoscopic bilateral adrenalectomy in a 30-year-old female with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86: 482-484.
43. Gmyrek GA, New MI, Sosa RE, Poppas DP. Bilateral laparoscopic adrenalectomy as a treatment for classic congenital adrenal hyperplasia attributable to 21-hydroxylase deficiency. Pediatrics 2002; 109: e28.
44. Gunther DF, Bukowski TP, Ritzén EM, Wedell A, Van Wyk JJ. Prophylactic adrenalectomy of a three-year-old girl with congenital adrenal hyperplasia: pre- and postoperative studies. J Clin Endocrinol Metab 1997; 82: 3324-3327.
45. Dewailly D, Vantyghem-Haudiquet MC, Sainsard C, Buvat J, Cappoen JP, Ardaens K, Racadot A, Lefebvre J, Fossati P. Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency. J Clin Endocrinol Metab 1986; 63: 418-423.
46. Blanché H, Vexiau P, Clauin S, Le Gall I, Fiet J, Mornet E, Dausset J, Bellanne-Chantelot C. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women. Hum Genet 1997; 101: 56-60.
47. Lajic S, Clauin S, Robins T, Vexiau P, Blanché H, Bellanne-Chantelot C, Wedell A. Novel mutations in CYP21 detected in individuals with hyperandrogenism. J Clin Endocrinol Metab 2002; 87: 2824-2829.
48. Baumgartner-Parzer SM, Pauschenwein S, Waldhäusl W, Polzler K, Nowotny P, Vierhapper H. Increased prevalence of heterozygous 21-OH germline mutations in patients with adrenal incidentalomas. Clin Endocrinol 2002; 56: 811-816.